Clinical Trials Directory

Trials / Completed

CompletedNCT00284453

Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm

Gene Expression in ICD Patients With Electrical Storm

Status
Completed
Phase
Study type
Observational
Enrollment
65 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the proposed pilot study is to identify factors which are associated with periods of high ventricular arrhythmia burden. This will be performed by analysis of gene expression from peripheral blood samples.

Detailed description

This is a study of patients with ICD implants who present with multiple(\>2), low-level(1-2) or inappropriate therapies to their defibrillator. The purpose of this pilot study is to identify factors which are associated with periods of high ventricular arrhythmia burden by looking at gene expression from peripheral blood, in addition to levels of known markers of CHF, including catecholamine levels, B-type natriuretic peptide, and troponin. This study hypothesizes that extrinsic or systemic factors play a role in triggering these events, and if true should yield candidate proteins which would spawn functional studies to prove a role in causation. Additionally, identification of a marker of increased recurrence of events may aid in guiding therapy (starting an anti-arrhythmic versus awaiting the next event).

Conditions

Interventions

TypeNameDescription
PROCEDUREPeripheral blood samplingblood samples will be collected within 72 hours of subjects receiving \>2, 1-2(low level) or inappropriate therapies, device data and repeat bloodwork in 3 months(+/- 4weeks).

Timeline

Start date
2008-08-26
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2006-01-31
Last updated
2019-02-12

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00284453. Inclusion in this directory is not an endorsement.